Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Evaluating the effectiveness of zero based budgeting against traditional methods can guide your financial decisions. Explore which works best.
20,160 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
A new analysis finds the pandemic born cohort of first and second graders continues to lag in math and reading compar...
Alphabet is stepping up its AI game, signaling big potential and bigger risks for investors. This piece breaks down w...
Costco Wholesale trades around $975, dipping under the $1,000 mark. This guide analyzes whether should costco wholesa...
A former social security commissioner argues for higher taxes on the wealthy to shore up Social Security. The idea so...
Bed Bath & Beyond is expanding beyond retail into real estate and homeowner services with a $53.38 million all-stock ...
A veteran observer warns that AI's impact extends beyond jobs, threatening cultural norms and household finances. The...
Jack in the Box reported softer results in its latest quarter, bringing attention to jack box's revenue sales trends....
As AI expands, the backbone—data centers and compute—becomes a focal point for investors. This guide compares CoreWea...
United Airlines faces near term pressure from higher fuel costs, yet the Street remains optimistic with a consensus t...
This week brings four major earnings reports that could reveal trends in consumer spending, AI demand, and corporate ...
PepsiCo deploys another round of price cuts on its snack lineup to lure budget-conscious shoppers as geopolitical ten...